Jonathan Allan, GENERAL COUNSEL & Corporate Secretary at Stoke Therapeutics, Inc. (STOK), sold 4,576 shares at $30.85 ($138K) on 2025-12-03, disclosed to the SEC on 2025-12-03.
Open-market sale of $138k STOK by GENERAL COUNSEL & Corporate Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.56 | 1,416 | $42K | 30.3% |
| 2 | $30.14 | 868 | $26K | 18.9% |
| 3 | $30.34 | 898 | $27K | 19.7% |
| 4 | $30.85 | 1,394 | $43K | 31.1% |
| Total | $30.22 avg | 4,576 | $138K | 100% |
| Filing → |
| STOK | SELL | 2026-06-18 | $44K | — | Filing → |
| STOK | SELL | 2026-03-24 | $626K | — | Filing → |
| STOK | SELL | 2026-03-19 | $569K | — | Filing → |